IQSM Fact Sheet: NYLIM Candriam U.S. Mid Cap Equity ETF
Share
$38.63
close, Nov 18, 2026
Over the year to Nov 18, 2026, IQSM returned +17.6% in total and charged 0.15% a year.
- 1-year total return
- +17.6%
- IWV +12.0% to Nov 18, 2026
- Expense ratio
- 0.15%
- a year
- Net flow, 12 months to Jul 31, 2026
- +$72.5m
- monthly N-PORT basis to Jul 31, 2026
Growth of $10,000, 1 year
IQSM $11,760 +17.6% · IWV $11,199 +12.0% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.
Returns
WindowTotal return
1 month+0.7%
3 months−5.2%
Year to date+12.4%
1 year+17.6%
3 years+48.6%
Total return, distributions reinvested, each window to Nov 18, 2026.
Ten largest positions
HoldingWeight
REVOLUTION MEDICINES INC1.32%
TWILIO INC1.01%
NVENT ELECTRIC PLC0.93%
BURLINGTON STORES INC0.93%
US FOODS HOLDING CORP0.92%
OKTA INC0.90%
F5 INC0.88%
GUARDANT HEALTH INC0.83%
VIATRIS INC0.78%
MKS INC0.76%
IQSM top ten by weight, 9.2% of the fund, of its 246 equity positions, from the holdings filed for Jul 31, 2026.
Facts
Equity fund · Tracks the NYLI Candriam U.S. Mid Cap Equity Index · First traded Oct 25, 2022 · Benchmark Russell 3000 Index, measured by IWV, which tracks the same index